Acquired
Novo Nordisk (Ozempic)
David Rosenthal
I think this is going to be like insulin all over again, where there's just going to be a series of product improvements and companies will drive innovation and increase supply. I mean, the demand is so huge out there that Monjaro can be a huge hit. Ozempic and Wegabee will continue to be huge hits. Other companies getting into the game will be huge hits.
0
💬
0
Comments
Log in to comment.
There are no comments yet.